 WES MOORE, Governor  Ch. 885  
 
– 1 – Chapter 885  
(House Bill 1155 ) 
 
AN ACT concerning  
 
Hospitals – Opioid Overdose – Medication –Assisted Treatment  and  
Opioid–Related Emergency Medical Conditions – Treatment  
 
FOR the purpose of requiring hospitals to establish and maintain certain protocols and 
capacity related to the treatment of patients who are being treated for an  
opioid –related overdose or opioid –related emergency medical condition ; requiring 
hospitals to connect  make a referral for  patients who are diagnosed with opioid use 
disorder or  administered or prescribed medication –assisted treatment  medication 
for opioid use disorder  to an appropriate provider to voluntarily continue treat ment 
in the community  under certain circumstances and work with peer support 
professionals for a certain purpose ; requiring the Governor to include in the annual 
budget bill for a certain fiscal year a certain appropriation from the Opioid 
Restitution Fund  for hospitals to provide training and resources to implement the 
requirements of this Act;  and generally relating to hospitals and treatment for opioid 
use disorder and opioid –related emergency medical conditions . 
 
BY adding to  
 Article – Health – Gener al 
Section 19 –308.10  
 Annotated Code of Maryland  
 (2023 Replacement Volume)  
 
BY repealing and reenacting, with amendments,  
 Article – State Finance and Procurement  
Section 7 –331 
 Annotated Code of Maryland  
 (2021 Replacement Volume and 2023 Supplement)  
 
 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 
That the Laws of Maryland read as follows:  
 
Article – Health – General  
 
19–308.10.  
 
 (A) (1) IN THIS SECTION THE FOLLOWING WORDS HAVE THE MEANINGS  
INDICATED . 
 
  (2) “MEDICATION ” MEANS , “MEDICATION FOR OPIOI D USE 
DISORDER ”: 
Ch. 885  2024 LAWS OF MARYLAND   
 
– 2 –  
  (1) MEANS  A DRUG APPROVED BY T HE U.S.  FOOD AND DRUG 
ADMINISTRATION FOR TH E TREATMENT OF OPIOI D USE DISORDER ; AND 
 
  (2) DOES NOT INCLUDE A DR UG ADMINISTERED TO M ITIGATE 
OPIOID–RELATED OVERDOSE SYM PTOMS . 
 
  (3) “MEDICATION –ASSISTED TREATMENT ” MEANS THE USE OF  
MEDICATION , IN COMBINATION WITH COUNSELING AND BEHAV IORAL HEALTH  
THERAPIES , TO PROVIDE A HOLISTI C APPROACH TO THE TR EATMENT OF OPIOID US E 
DISORDER . 
 
  (4) “OPIOID USE DISORDER ” MEANS A MEDICALLY DI AGNOSED  
PROBLEMATIC PATTERN OF  OPIOID USE THAT CAUS ES A SIGNIFICANT IMP AIRMENT  
OR DISTRESS . 
 
 (B) EACH HOSPITAL SHALL E STABLISH AND MAINTAI N, AS PART OF ITS 
EMERGENCY SERVICES , PROTOCOLS AND CAPACI TY TO : 
 
  (1) PROVIDE TO A PATIENT BEFORE DISCHARGING T HE PATIENT 
APPROPRIATE , EVIDENCE –BASED INTERVENTIONS THAT REDUCE THE RISK  OF 
SUBSEQUENT HARM AND FATALITY FOLLOWING A N OPIOID –RELATED OVERDOSE OR 
A VISIT FOR AN OPIOI D–RELATED EMERGENCY ME DICAL CONDITION ;  
 
  (2) POSSESS , DISPENSE , ADMINISTER , AND PRESCRIBE  
MEDICATION –ASSISTED TREATMENT , INCLUDING  AT LEAST ONE FORMULA TION OF 
EACH U.S.  FOOD AND DRUG ADMINISTRATION –APPROVED FULL OPIOID  AGONIST , 
AND  PARTIAL OPIOID AGONI ST, AND LONG –ACTING OPIOID ANTAGO NIST  USED FOR 
THE  TREATMENT OF OPIOID USE DISORDER ; AND  
 
  (3) TREAT A PATIENT WHO P RESENTS IN A HOSPITA L EMERGENCY 
DEPARTMENT FOR CARE AND TREATMENT OF AN OPIOID–RELATED OVERDOSE OR 
OPIOID–RELATED EMERGENCY ME DICAL CONDITION WITH  A MEDICATION FOR 
OPIOID USE DISORDER  IF TH E TREATMENT : 
 
   (I) OCCURS AS RECOMMENDED  BY THE TREATING HEAL TH 
CARE PRACTITIONER ; AND 
 
   (II) IS VOLUNTARILY AGREED  TO BY THE PATIENT . 
 
 (C) A PROTOCOL ESTABLISHED  BY A HOSPITAL UNDER THIS SECTION SHALL  
COMPLY WITH  INCLUDE : 
 
 WES MOORE, Governor  Ch. 885  
 
– 3 –   (1) APPLICABLE TRAINING AND WAIVER REQUIREME NTS 
ESTABLISHED BY THE F EDERAL DRUG ENFORCEMENT AGENCY ; AND  
 
  (2) ANY REQUIREMENT BY TH E DEPARTMENT REGARDING 
PRESCRIBING OPIOID A GONIST TREATMENT ; 
 
  (2) UNIFORM PRACTICES FOR  SCREENING AND DIAGNO SING 
INDIVIDUALS WHO PRES ENT WITH AN O PIOID–RELATED OVERDOSE OR  
OPIOID–RELATED EMERGENCY ME DICAL CONDITION FOR AN OPIOID USE DISORD ER 
BASED ON THE CRITERI A IN THE MOST RECENT  EDITION OF THE DIAGNOSTIC AND 
STATISTICAL MANUAL OF MENTAL DISORDERS ; 
 
  (3) UNIFORM PRACTICES FOR  OFFERING AND ADMINI STERING 
OPIOID AGONIST MEDIC ATION TO TREAT AN OP IOID–RELATED OVERDOSE OR 
OPIOID USE DISORDER ; AND  
 
  (4) UNIFORM PRACTICES TO IDENTIFY COMMUNITY –BASED 
TREATMENT SERVICES T HAT ARE APPROPRIATE FOR: 
 
   (I) TREATING OPIOID USE D ISORDERS ; AND 
 
   (II) ASSISTING PATIENTS TO  VOLUNTARILY ACCESS O NGOING 
COMMUNITY –BASED TREATMENT AT D ISCHARGE .  
 
 (D) BEFORE DISCHARGING A PATIENT WHO IS DIAGNOSED WITH AN OP IOID 
USE DISORDER OR  ADMINISTERED OR PRES CRIBED MEDICATION –ASSISTED 
TREATMENT  MEDICATION FOR OPIOI D USE DISORDER , A HOSPITAL SHALL CONNECT  
THE PATIENT WITH AN APPROPRIATE PROVIDER  OR FACILITY TO VOLUN TARILY  
CONTINUE TREATMENT : 
 
  (1) MAKE A REFERRAL OF TH E PATIENT TO AN APPR OPRIATE 
PROVIDER OR FACILITY  FOR A TIMELY APPOINT MENT , WHEN POSSIBLE , TO 
VOLUNTARILY CONTINUE TREATMENT I N THE COMMUNITY ; AND  
 
  (2) WORK WITH PEER SUPPOR T PROFESSIONALS , AS AVAILABLE , OR 
OTHER RESOURCES TO A SSIST THE PATIENT IN  ACCESSING THE IDENTI FIED 
TREATMENT SERVICES . 
 
Article – State Finance and Procurement  
 
7–331. 
 
 (a) In this section, “Fund” means the Opioid Restitution Fund.  
 
Ch. 885  2024 LAWS OF MARYLAND   
 
– 4 –  (b) There is an Opioid Restitution Fund.  
 
 (c) The purpose of the Fund is to retain the amount of settlement revenues 
deposited to the Fund in accordance with subsection (e)(1) of this section.  
 
 (d) (1) The Fund is a special, nonlapsing fund that is not subject to § 7 –302 of 
this subtitle.  
 
  (2) The State Treasurer shall hold the Fund separately, and the 
Comptroller shall account for the Fund.  
 
 (e) The Fund consists of:  
 
  (1) all revenues received by the State from any source resulting, directly or 
indirectly, from any judgment against, or settlement with, opioid manufacturers, opioid 
research associations, or any other person in the opioid industry relating to any claims 
made or prosecuted by the Stat e to recover damages for violations of State law; and  
 
  (2) the interest earnings of the Fund.  
 
 (f) The Fund may be used only to provide funds for:  
 
  (1) programs, services, supports, and resources for evidence –based 
substance use disorder prevention, t reatment, recovery, or harm reduction that have the 
purpose of:  
 
   (i) improving access to medications proven to prevent or reverse an 
overdose;  
 
   (ii) supporting peer support specialists and screening, brief 
intervention, and referral to treatment services for hospitals, correctional facilities, and 
other high –risk populations;  
 
   (iii) increasing access to medications that support recovery from 
substance use disorders;  
 
   (iv) expanding the Heroin Coordinator Program, including for 
administrative  expenses;  
 
   (v) expanding access to crisis beds and residential treatment 
services for adults and minors;  
 
   (vi) expanding and establishing safe stations, mobile crisis response 
systems, and crisis stabilization centers;  
 
   (vii) supporting the behav ioral health crisis hotline;  
 WES MOORE, Governor  Ch. 885  
 
– 5 –  
   (viii)  organizing primary and secondary school education campaigns 
to prevent opioid use, including for administrative expenses;  
 
   (ix) enforcing the laws regarding opioid prescriptions and sales, 
including for administra tive expenses;  
 
   (x) research regarding and training for substance use treatment and 
overdose prevention, including for administrative expenses; and  
 
   (xi) supporting and expanding other evidence –based interventions 
for overdose prevention and substance use treatment;  
 
  (2) evidence –informed substance use disorder prevention, treatment 
recovery, or harm reduction pilot programs or demonstration studies that are not  
evidence –based if the Opioid Restitution Fund Advisory Council, established und er §  
7.5–902 of the Health – General Article:  
 
   (i) determines that emerging evidence supports the distribution of 
money for the pilot program or that there is a reasonable basis for funding the 
demonstration study with the expectation of creating an ev idence –based program; and  
 
   (ii) approves the use of money for the pilot program or demonstration 
study; and  
 
  (3) evaluations of the effectiveness and outcomes reporting for substance 
use disorder abatement infrastructure, programs, services, supports,  and resources for 
which money from the Fund was used, including evaluations of the impact on access to 
harm reduction services or treatment for substance use disorders and the reduction in 
drug –related mortality.  
 
 (g) (1) The State Treasurer shall invest  the money of the Fund in the same 
manner as other State money may be invested.  
 
  (2) Any interest earnings of the Fund shall be credited to the Fund.  
 
 (h) (1) Expenditures from the Fund may be made only in accordance with the 
State budget.  
 
  (2) FOR FISCAL YEAR 2026,  THE GOVERNOR SHALL INCLUD E IN THE  
ANNUAL BUDGET BILL A N APPROPRIATION OF $500,000  FROM THE FUND TO  
PROVIDE TRAINING AND  RESOURCES TO HOSPITA LS TO IMPLEMENT THE  
REQUIREMENTS OF § 19–308.10  OF THE HEALTH – GENERAL ARTICLE . 
 
  [(2)] (3) For settlement funds received in accordance with the final 
distributor agreement of July 21, 2021, with McKesson Corporation, Amerisource Bergen 
Ch. 885  2024 LAWS OF MARYLAND   
 
– 6 – Corporation, and Cardinal Health Incorporated, as amended, the Janssen settlement 
agreement of July 21, 2021, as am ended, or any other opioid –related court or 
administrative judgment or settlement agreement involving the State and one or more of 
its political subdivisions:  
 
   (i) appropriations from the Fund in the State budget shall be made 
in accordance with the all ocation and distribution of funds to the State and its political 
subdivisions:  
 
    1. as agreed on in the State –subdivision agreement of 
January 21, 2022, as amended; or  
 
    2. required under any other opioid –related court or 
administrative judgment or s ettlement agreement, or any similar agreement reached under 
an opioid –related court or administrative judgment or settlement agreement, involving the 
State and one or more of its political subdivisions; and  
 
   (ii) the Secretary of Health shall establish and administer a grant 
program for the distribution of funds to political subdivisions of the State in accordance 
with:  
 
    1. the State –subdivision agreement of January 21, 2022, as 
amended; or  
 
    2. the requirements of any other opioid –related court or 
administrative judgment or settlement agreement, or any similar agreement reached under 
an opioid –related court or administrative judgment or settlement agreement, involving the 
State and one or more of its political subdivisions.  
 
  [(3)] (4) The Attor ney General shall identify and designate the 
controlling version of any agreement or amendment described under paragraph [(2)] (3) of 
this subsection.  
 
 (i) (1) Money expended from the Fund for the programs and services described 
under subsection (f) of th is section is supplemental to and is not intended to take the place 
of funding that otherwise would be appropriated for the programs and services.  
 
  (2) Except as specified in subsection (f) of this section, money expended 
from the Fund may not be used fo r administrative expenses.  
 
 (j) The Governor shall:  
 
  (1) develop key goals, key objectives, and key performance indicators 
relating to substance use treatment and prevention efforts;  
 
 WES MOORE, Governor  Ch. 885  
 
– 7 –   (2) subject to subsection [(h)(2) ] (H)(3) of this section, at least  twice 
annually, consult with the Opioid Restitution Fund Advisory Council to identify 
recommended appropriations from the Fund; and  
 
  (3) report on or before November 1 each year, in accordance with § 2 –1257 
of the State Government Article, to the Gener al Assembly on:  
 
   (i) an accounting of total funds expended from the Fund in the 
immediately preceding fiscal year, by:  
 
    1. use; 
 
    2. if applicable, jurisdiction; and  
 
    3. budget program and subdivision;  
 
   (ii) the performance indicators and progress toward achieving the 
goals and objectives developed under item (1) of this subsection; and  
 
   (iii) the recommended appropriations from the Fund identified in 
accordance with item (2) of this subsection.  
 
 SECTION 2. AND BE IT FURTHER ENACTED, Th at: 
 
 (a) The Maryland Department of Health shall study whether and how funding 
from the Opioid Restitution Fund can be used to provide training and resources to hospitals 
to implement Section 1 of the Act, including a recommended funding amount.  
 
 (b) On or before January 1, 2025, the Department shall report its findings and 
recommendations to the Senate Finance Committee and House Health and Government 
Operations Committee, in accordance with § 2 –1257 of the State Government Article.  
 
 SECTION 3. AND BE I T FURTHER ENACTED, That Section 1 of this Act shall take 
effect January 1, 2025.  
 
 SECTION 2. 4. 2. AND BE IT FURTHER ENACTED, That , except as provided in 
Section 3 of this Act,  this Act shall take effect October 1, 2024  January 1, 2025 . 
 
Approved by the Governor, May 16, 2024.  